Navid Koleini, MD., PhD Candidate (Kardami Lab) won a travel award and best presentation award at the recent 10th Canadian Oxidative Stress Consortium in Edmonton, Alberta, for his poster entitled “Elimination or neutralization of endogenous high molecular weight FGF-2 increases cardiac resistance to Doxorubicin-induced damage”.
The Canadian Oxidative Stress Consortium (COSC) aims at advancement of research and education in oxidative stress in health and disease. Oxidative stress has implications for a broad range of disorders including ischemia-reperfusion injury, stroke, diabetes, cardiovascular diseases, arthritis, cancer, neurodegenerative diseases (Alzheimer’s, Parkinson’s), spinal cord injury, sepsis, inflammation and respiratory diseases, etc. Initiated in July 1999 by Dr. Ashok Grover (McMaster University), with support from the Canadian Institutes for Health Research, the COSC consists of researchers from about 50 laboratories from 15 different universities in Canada. Its goal is to foster research collaboration among these laboratories, to provide better training opportunities for students and postdoctoral fellows working in them and to foster closer ties between its members and the pharmaceutical industry.
Congratulations Dr. Koleini!!